BlackRock’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-210,981
| Closed | -$131K | – | 5097 |
|
2018
Q4 | $131K | Sell |
210,981
-995
| -0.5% | -$618 | ﹤0.01% | 4260 |
|
2018
Q3 | $275K | Buy |
211,976
+3,694
| +2% | +$4.79K | ﹤0.01% | 4197 |
|
2018
Q2 | $281K | Sell |
208,282
-1,101,220
| -84% | -$1.49M | ﹤0.01% | 4186 |
|
2018
Q1 | $1.9M | Buy |
1,309,502
+6,385
| +0.5% | +$9.26K | ﹤0.01% | 3646 |
|
2017
Q4 | $2.93M | Buy |
1,303,117
+14,908
| +1% | +$33.5K | ﹤0.01% | 3547 |
|
2017
Q3 | $4.38M | Buy |
1,288,209
+51,882
| +4% | +$176K | ﹤0.01% | 3447 |
|
2017
Q2 | $4.39M | Buy |
1,236,327
+114,034
| +10% | +$405K | ﹤0.01% | 3458 |
|
2017
Q1 | $3.82M | Buy |
1,122,293
+1,121,035
| +89,112% | +$3.81M | ﹤0.01% | 3433 |
|
2016
Q4 | $6K | Hold |
1,258
| – | – | ﹤0.01% | 3454 |
|
2016
Q3 | $5K | Hold |
1,258
| – | – | ﹤0.01% | 3460 |
|
2016
Q2 | $3K | Buy |
1,258
+1,022
| +433% | +$2.44K | ﹤0.01% | 3582 |
|
2016
Q1 | $1K | Buy |
+236
| New | +$1K | ﹤0.01% | 3574 |
|